The Arab Drug Company (EGX:ADCI)
Egypt flag Egypt · Delayed Price · Currency is EGP
238.94
-4.06 (-1.67%)
At close: Jun 25, 2026

The Arab Drug Company Cash Flow Statement

Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Income
259.55227.86102.8282.7776.3101.41
Depreciation & Amortization
25,35225,3613.373.269.397.81
Other Operating Activities
-25,375-25,42429.581.48-52.82-72.65
Operating Cash Flow
236.58164.28135.7787.5132.8736.58
Operating Cash Flow Growth
52.35%21.00%55.15%166.22%-10.14%-50.05%
Capital Expenditures
-132.19-198.9-285.98-63.18-89.92-28.87
Investment in Securities
----13.88-
Other Investing Activities
8.6619.2727.921.071.634.34
Investing Cash Flow
-123.52-179.63-258.07-62.11-74.41-24.53
Short-Term Debt Issued
----27.33-
Long-Term Debt Issued
-35.79339.0951.352.54-
Total Debt Issued
50.0235.79339.0951.379.87-
Long-Term Debt Repaid
--97.24-44.55---
Total Debt Repaid
-92.35-97.24-44.55---
Net Debt Issued (Repaid)
-42.33-61.46294.5451.379.87-
Common Dividends Paid
-107.66-63.11-36.1-37.49-43.54-38.85
Other Financing Activities
-62.25-48.56-23.09-1.68-0.95-
Financing Cash Flow
-212.24-173.12235.3512.1335.38-38.85
Miscellaneous Cash Flow Adjustments
32.4135.0469.18-27.33--0
Net Cash Flow
-66.77-153.44182.2410.2-6.15-26.8
Free Cash Flow
104.4-34.63-150.2224.33-57.047.71
Free Cash Flow Growth
------89.09%
Free Cash Flow Margin
7.87%-3.10%-19.12%3.84%-11.29%1.44%
Free Cash Flow Per Share
7.85-2.89-12.522.03-4.210.56
Cash Interest Paid
13.8848.5623.091.680.95-
Cash Income Tax Paid
12.2947.1834.7335.0951.9552.97
Levered Free Cash Flow
25,34525,184-184.62-24.95-121.56-1.96
Unlevered Free Cash Flow
25,38425,214-170.19-23.5-120.96-1.93